Why BioNTech Stock Is Getting Crushed Today
German biopharma outfit BioNTech SE reported lackluster fiscal Q4 results on Tuesday. Guidance for the year now underway is just as disappointing.
Open original sourceLoading market dashboard
German biopharma outfit BioNTech SE reported lackluster fiscal Q4 results on Tuesday. Guidance for the year now underway is just as disappointing.
Open original source